Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A J Byrne

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Genes|December 24, 2021
Genetic Insights into the Impact of Complement in Alzheimer's DiseaseMegan Torvell, Sarah M Carpanini, Nikoleta Daskoulidou, et al.
Molecular Neurobiology|May 18, 2021
Novel Monoclonal Antibodies Against Mouse C1q: Characterisation and Development of a Quantitative ELISA for Mouse C1qRobert A J Byrne, Megan Torvell, Nikoleta Daskoulidou, et al.
Clinical Science (London, England : 1979)|March 20, 2024
The complement system in neurodegenerative diseasesJacqui Nimmo, Robert A J Byrne, Nikoleta Daskoulidou, et al.
Acta Neuropathologica Communications|July 6, 2022
Terminal complement pathway activation drives synaptic loss in Alzheimer's disease modelsSarah M Carpanini, Megan Torvell, Ryan J Bevan, et al.
Plos Genetics|January 27, 2025
Wild-type bone marrow cells repopulate tissue resident macrophages and reverse the impacts of homozygous CSF1R mutationDylan Carter-Cusack, Stephen Huang, Sahar Keshvari, et al.
Brain, Behavior, and Immunity|March 20, 2025
The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humansRobert A J Byrne, Jacqui Nimmo, Megan Torvell, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Genes|December 24, 2021
Genetic Insights into the Impact of Complement in Alzheimer's DiseaseMegan Torvell, Sarah M Carpanini, Nikoleta Daskoulidou, et al.
Molecular Neurobiology|May 18, 2021
Novel Monoclonal Antibodies Against Mouse C1q: Characterisation and Development of a Quantitative ELISA for Mouse C1qRobert A J Byrne, Megan Torvell, Nikoleta Daskoulidou, et al.
Clinical Science (London, England : 1979)|March 20, 2024
The complement system in neurodegenerative diseasesJacqui Nimmo, Robert A J Byrne, Nikoleta Daskoulidou, et al.
Acta Neuropathologica Communications|July 6, 2022
Terminal complement pathway activation drives synaptic loss in Alzheimer's disease modelsSarah M Carpanini, Megan Torvell, Ryan J Bevan, et al.
Plos Genetics|January 27, 2025
Wild-type bone marrow cells repopulate tissue resident macrophages and reverse the impacts of homozygous CSF1R mutationDylan Carter-Cusack, Stephen Huang, Sahar Keshvari, et al.
Brain, Behavior, and Immunity|March 20, 2025
The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humansRobert A J Byrne, Jacqui Nimmo, Megan Torvell, et al.
Pageof 1